Subscribe
Charles Woodburn's salary and options have risen on the back of a stronger share price
No Free Lunch: Both public spats were unncessary and avoidable
Many rushed to the conclusion he benefitted from higher energy prices and bumper British Gas profits
Investors have lost their money in early-stage pharmaceutical company 4D. What went wrong?
No Free Lunch: The company is no stranger to management problems
Two chief executives disagree about the company’s prospects
But what about the ethics of mining black gold?
The failure of Bulb highlights a catalogue of errors and weaknesses. Will we learn from its collapse?
Would De La Rue’s struggling businesses benefit from different management?
The Autumn Statement was a missed opportunity to make the property market fairer